Pharmaceutical and biotech companies spent $85bn on acquisitions in the first five months of the year, marking a dramatic recovery in dealmaking as they seek to replenish their drug pipelines.
今年头5个月，制药和生物技术公司在收购上花费了850亿美元，这标志着交易的巨大复苏，而它们正在寻求补充药物管线。
您已阅读2%（248字），剩余98%（10031字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。